Lev Pharmaceuticals
New York, New York, United States
About Lev Pharmaceuticals
Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York. As of October 21, 2008, Lev Pharmaceuticals, Inc. operates as a subsidiary of ViroPharma Inc.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $41.0M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2007)
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/lev-pharmaceuticals-2530140 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.